Prostate cancer exosomes as molecular predictors of response to therapy
Prostate cancer is the second most common cancer in men and acording to the Globocan report from 2012, there will be over 1.2 million new cases and over 300 000 deaths, worldwide. Organ-defined prostate cancer is a curable disease, but then it develops into metastatic castration resistant prostate c...
Autor principal: | |
---|---|
Formato: | masterThesis |
Idioma: | eng |
Publicado em: |
2016
|
Assuntos: | |
Texto completo: | http://hdl.handle.net/10362/17910 |
País: | Portugal |
Oai: | oai:run.unl.pt:10362/17910 |